Annals
Established in 1927 by the American College of Physicians
:
Advanced search
 
box Article
 arrow  Table of Contents                
space
box Services
 arrow  Send comment/rapid response letter
space
 arrow  Notify a friend about this article
space
 arrow  Alert me when this article is cited
space
 arrow  Add to Personal Archive
space
 arrow  Download to Citation Manager
space
 arrow  ACP Search                        
space
 arrow  Get Permissions
space
box Google Scholar
 arrow  Search for Related Content
space
box PubMed
Articles in PubMed by Author:
  arrow  Alberich, R. S.
space
  arrow  Masana, L.
space
 arrow  PubMed                        
space

LETTER

Henoch-Schonlein Purpura Associated with Acetylsalicylic Acid

right arrow Rosa Sola Alberich, MD, PhD; Ali Jammoul, MD; and Luis Masana, MD, PhD

15 April 1997 | Volume 126 Issue 8 | Page 665


TO THE EDITOR:

We describe a patient who had clinical and anatomopathologic findings that were compatible with Henoch-Schonlein purpura [1] and were associated with intake of acetylsalicylic acid. For 1 week, a 60-year-old man had red spots that were related to mild edema of his legs, ankle arthralgias, and colicky abdominal pain associated with the rectal passage of blood. He had been taking acetylsalicylic acid (500 mg/d) for the past 5 years. After he stopped taking the drug, all signs and symptoms resolved except for mild pain in both ankles. The patient then resumed taking acetylsalicylic acid (this time at a dosage of 900 mg/d). Three days later, the red spots reappeared.

Physical examination showed arterial hypertension (blood pressure, 210/120 mm Hg) and palpable purpura on the lower extremities. No signs of rectal bleeding were detected. Platelet counts and results of tests for coagulation were normal. The blood creatinine level was 128 µmol/L, and the C-reactive protein level was 34 mg/L. Results of tests for antinuclear antibodies, cryoglobulins, C3, and C4 were negative. Urinary protein excretion was 1 g/24 hours, and urinary sediment showed microscopic hematuria. Skin biopsy showed fibrinoid necrosis and inflammatory infiltration accompanied by endothelial tumefaction that was compatible with leukocytoclastic vasculitis. Immunofluorescence studies of the dermal capillaries showed IgA deposits.

To our knowledge, this is the first case of Henoch-Schonlein purpura [1] associated with acetylsalicylic acid and confirmed by the characteristic deposits of IgA in the vascular wall [2]. Although drugs can intervene [3, 4], there is no clear etiologic association with Henoch-Schonlein purpura. However, the fact that the symptoms and signs rapidly resolved after therapy with the drug was stopped and reappeared after use of acetylsalicylic acid resumed allows us to report that the Henoch-Schonlein purpura was a drug-induced reaction [1, 4].


Author and Article Information
space
up arrowTop
dotAuthor & Article Info
down arrowReferences

Universitat Rovira i Virgili, 43201 Reus, Spain


References
space
up arrowTop
up arrowAuthor & Article Info
dotReferences

1. American College of Rheumatology. Criteria for the classification of vasculitis. Arthritis Rheum. 1990; 33:1065-136.

2. Van Hale HM, Gibson LE, Schroeter AL. Henoch-Schonlein vasculitis: direct immunofluorescence study of uninvolved skin. J Am Acad Dermatol. 1986; 15:665-70.[Medline]

3. Goebel KM, Mueller-Brodmann W. Reversible overt nephropathy with Henoch-Schonlein purpura due to piroxicam. Br Med J. 1982; 284:311-2.

4. Roujeau JC, Stern RS. Medical progress: severe adverse cutaneous reactions to drugs. N Engl J Med. 1994; 331:1272-85.

About Letters
space

The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:

•Include no more than 300 words of text, three authors, and five references

•Type with double-spacing

•Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.

Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified about 3 weeks before the publication date. Unpublished letters cannot be returned.

Annals welcomes electronically submitted letters.





box Article
 arrow  Table of Contents                
space
box Services
 arrow  Send comment/rapid response letter
space
 arrow  Notify a friend about this article
space
 arrow  Alert me when this article is cited
space
 arrow  Add to Personal Archive
space
 arrow  Download to Citation Manager
space
 arrow  ACP Search                        
space
 arrow  Get Permissions
space
box Google Scholar
 arrow  Search for Related Content
space
box PubMed
Articles in PubMed by Author:
  arrow  Alberich, R. S.
space
  arrow  Masana, L.
space
 arrow  PubMed                        
space


 Home | Current Issue | Past Issues | In the Clinic | ACP Journal Club | CME | Collections | Audio/Video | Mobile | Subscribe | Tools | Help | ACP Online